Unresectable stage III non-small cell lung cancer: Insights from a Portuguese expert panel-Reference-Cited by-同舟云学术

Unresectable stage III non-small cell lung cancer: Insights from a Portuguese expert panel

Published:2023-01 Issue: Volume: Page:
ISSN:2531-0437
Container-title:Pulmonology
language:en
Short-container-title:Pulmonology

Author:

Araújo A.^ORCID,Barroso A.,Parente B.,Travancinha C.,Teixeira E.,Martelo F.,Fernandes G.,Paupério G.,Queiroga H.,Duarte I.,da Costa J.D.,Soares M.^ORCID,Borralho P.,Costa P.,Chinita P.,Almodôvar T.,Barata F.

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference59 articles.

1. Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer;Cheema;Curr Oncol,2019

2. TNM Classification of Malignant Tumours;Brierley,2017

3. Recent trends in the treatment of unresectable stage III non-small-cell lung cancer;Makimoto;Respir Investig,2019

4. Tools used in the diagnosis and staging of lung cancer: what's old and what's new?;Currie;QJM An Int J Med,2009

5. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer;Furuse;J Clin Oncol,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study;Signal Transduction and Targeted Therapy;2024-06-14

2. ETV6-NTRK2 Fusion in a Patient With Metastatic Pulmonary Atypical Carcinoid Successfully Treated With Entrectinib: A Case Report and Review of the Literature;Clinical Lung Cancer;2024-05